baber/WOPTO huggingface dataset:
Patent NZ-556678-A (NZ)
Title: A composite masonry building block
Inventor: BENNETT KERRY ROBERT
IPC: E04C1/40
Filed: 2006-01-04
Abstract: A composite masonry building block (1) that has an inner core (20) of lighter density than an outer face and includes upper most protrusions (4) and matching lowermost cavities (5) to have an interlocking arrangement with other like blocks. Also disclosed is an inner lighter density material which includes an expanded plastic such as polystyrene with a cement binder. The arrangement of the protrusions (4) in relation to the upper surface (2) and the arrangement of cavities (5) in relation to lower surface are such that the protrusions (4) will locate within and interlock with the consistently aligned and placed cavities of the adjacent block.
Patent NZ-566432-A (NZ)
Title: Dietary supplement composition
Inventor: JURGENS STEVE E
IPC: A23L33/00
Filed: 2006-09-14
Abstract: Disclosed is a pourable solid composition comprising water-soluble dietary fiber and calcium lactogluconate wherein said fiber is selected from the group consisting of partially hydrolyzed guar gum and a soluble dextrin prepared from wheat or maize starch, and wherein said calcium lactogluconate has a calcium content of higher than 10 weight percent.
Patent NZ-569258-A (NZ)
Title: Bis-platinum complexes with antitumor activity
Inventor: BERNAREGGI ALBERTO
IPC: A61K31/28
Filed: 2006-12-21
Abstract: Provided is a compound of formula (I), in which: R is (C3-C7)alkyl; n and m are each independently an integer of five or six; p is one or two; A is -B-(CH2),-B-, wherein r is an integer from 2 to 4, B is a -NR'- or -N(R2)2+ 1/pQ -P group, in which R1 is hydrogen or tert-butoxycarbonyl, and R2 is hydrogen; Q-P is an anion selected from chloride, bromide, iodide, nitrate, sulphate, hydrogen sulphate, perchlorate, R3COO- wherein R3 has the same meanings as R, independently from one another, and R4-O-SO3- wherein R4 is (C2-C 14)alkyl with the proviso that, when Q -P is selected from chloride, bromide, iodide, nitrate, sulphate, hydrogen sulphate, perchlorate, R is not (C3-C4)alkyl. The compounds are useful in treating tumours.
Patent NZ-569955-A (NZ)
Title: Medication order processing and reconciliation
Inventor: BATCH RICHARD M
IPC: G16H10/60
Filed: 2006-12-19
Abstract: A system for managing medication orders comprises a processor configured to receive a medication order containing medication administration information from a medication order source and a medication administration device in operable communication with the processor. The medication administration device is configured to receive medication administration information from the processor, and provide the processor with medication administration status information. The processor compares medication administration status information received from the medication administration device to the medication administration information in the medication order, and associates a new order identification number to the medication administration status information when the comparison determines that there is a difference between the medication status information and the medication administration information of the medication order.
Patent NZ-570684-A (NZ)
Title: Improved crystalline material
Inventor: CHIDAMBARAM RAMAKRISHNAN
IPC: A61K31/167
Filed: 2007-03-27
Abstract: The disclosure relates to crystalline forms of 3-[ [3, 5-dibromo-4-[4-hydroxy-3-(1-methylethyl)-phenoxy]-phenyl]-amino]-3-oxopropanoic acid, particularly disclosed is a crystalline form being characterised by a powder X-ray diffraction pattern having major peaks at 2-theta = 16.1 ±0.2, 20.1 ±0.2, 20.7 ±0.2, and 24.2 ±0.2.This crystalline material is useful for selectively agonizing the thyroid beta receptor and is suitable for treating a condition associated with thyroid disfunction, wherein the condition is obesity, hypercholesterolemia, atherosclerosis, depression, osteoporosis, hypothyroidism or subclinical hypothyroidism, non-toxic goiter, papillary or follicular thyroid cancer, glaucoma, cardiovascular disease, congestive heart failure, or a skin disorder.
Patent NZ-575273-A (NZ)
Title: Method for making combination vaccine comprising inactivated poliovirus type 1, diptheria toxoid and tetanus toxoid
Inventor: DE HEMPTINNE HERVE
IPC: A61K39/13
Filed: 2007-09-07
Abstract: A method of a making a combination vaccine that comprises inactivated poliovirus type 1. The method includes mixing diphtheria toxoid and tetanus toxoid, followed by the addition of greater than 10 D-antigen units and less than 20 D-antigen units of inactivated poliovirus type 1 per dose of the vaccine. The method can further comprise the addition of IPV types 2 and 3.
Patent NZ-576948-A (NZ)
Title: Self-assembling amphiphilic polymers as antiviral agents
Inventor: ONTON ANN LOUISE
IPC: A61K31/795
Filed: 2007-01-22
Abstract: Disclosed is a comb polymer consisting essentially of the structure of formula 1 comprising a backbone formed of alternating branch-point moieties B and hydrophilic water-soluble polymer blocks A; and having hydrophobic side chains C and ligands Z attached to the branch-point moieties, wherein: each hydrophobic side chain C is independently selected from the group consisting of C6-30 cyclic or polycyclic hydrocarbons optionally substituted with one or more hydrophilic substituents; C6-30- cyclic or polycyclic hydrocarbons optionally substituted with one or more hydrophilic substituents; and hydrophobic amino acids, peptides and polymers; each ligand Z is independently a ligand having specific binding affinity for the surface of said virus; s is a bond or a spacer moiety; the value of n ranges from 3 to about 100; the average value of p ranges from greater than one to four; and the average value of r ranges from 1 to 8. Also disclosed is the use of the comb polymer consisting essentially of the structure of formula 1 in the manufacture of a medicament for the treatment or prevention of an infection of an animal by a virus. Also disclosed are the peptides KDYRGWKOWVYYTC, KGWKHWVYC(NH2) and KGWKOWVYC(NH2).
Patent NZ-578391-A (NZ)
Title: Aryloxymethyloxadiazole derivative for the treatment of alopecia
Inventor: NAKAO AKIKO
IPC: A61K8/49
Filed: 2007-12-20
Abstract: Disclosed is the use of 1-[2-((2S)-2-{5-[(3,4-dimethoxyphenoxy)methyl]-1,2,4-oxadiazol-3-yl}pyrrolidin-1-yl)-1,1-difluoro-2-oxoethyl]-3,3,5,5-tetramethylcyclohexanol in the preparation of a medicament for the prophylaxis or treatment of alopecia in a mammal.
Patent NZ-580125-A (NZ)
Title: Automated control for detection of flow limitation
Inventor: ARMITSTEAD JEFFREY PETER
IPC: A61M16/00
Filed: 2008-05-09
Abstract: Disclosed is a method of detecting respiratory flow limitation and a device utilizing such a method. The method determines a flow limitation measure (506) based one or more shape indices (502) and a determined ventilation measure or respiratory duty cycle (504). The shape indices may be based on functions that ascertain the likelihood of the presence of M-shaped breathing patterns and/or chair-shaped breathing patterns. The measure of ventilation may be based on analysis of current and prior tidal volumes to detect a less than normal patient ventilation. The duty cycle measure may be a ratio of current and prior measures of inspiratory time to respiratory cycle time to detect an increase in the patient's inspiratory cycle time relative to the respiratory cycle time. Once the flow limitation has been determined, a pressure setting based on the flow limitation may be used to adjust the treatment pressure on a respiratory treatment device to ameliorate the patient's detected flow limitation condition.
Patent NZ-581633-A (NZ)
Title: 9-(Pyrazol-3-yl)-9H-purine-2-amine and 3-(pyrazol-3-yl)-3H-imidazo[4,5-b]pyridin-5-amine derivatives and their use for the treatment of cancer
Inventor: DAVIES AUDREY
IPC: A61P35/00
Filed: 2008-05-02
Abstract: Disclosed is N-[(1S)-1-(5-Fluoropyrimidin-2-yl)ethyl]-3-(5-isopropoxy-1H-pyrazol-3-yl)-3-H-imidazo[4,5-b]pyridin-5-amine or a pharmaceutically acceptable salt thereof for the treatment of cancer.
Patent NZ-586977-A (NZ)
Title: Inhaler with drive mechanism coupled to control element to index blister strip through inhaler
Inventor: EVANS PETER
IPC: A61M15/00
Filed: 2009-01-14
Abstract: 586977 An inhaler (10) is disclosed. It comprises a housing (12) to receive a strip (not shown) having a plurality of blisters, each blister having a breachable lid and containing a dose of medicament for inhalation by a user, an indexing wheel (15) mounted in the housing rotatable to drive a strip to sequentially move blisters into alignment with a blister piercing member (8), a control element (14) pivotally mounted to the housing and a drive mechanism (17) configured to couple the control element to the indexing wheel during part of the rotation of the control element by a user so that the indexing wheel rotates together with the control element.
Patent NZ-587115-A (NZ)
Title: Adhesive patch
Inventor: OKADA TOMOMI
IPC: A61P29/00
Filed: 2009-01-22
Abstract: Disclosed is an adhesive patch comprising a stretchable support and an adhesive layer laminated on at least one side of the support, wherein the stretchable support comprises a woven fabric knitted in stockinette stitch on both sides having two or more rows of crimped polyethylene terephthalate multifilament yarns, the adhesive layer contains 25 to 50 percent by mass of a liquid organic ingredient and 25 to 50 percent by mass of a thermoplastic elastomer based on the total mass of the layer and contains 10 percent by mass or more of methyl salicylate in the liquid organic ingredient based on the total mass of the layer.
Patent NZ-587700-A (NZ)
Title: A connector for adjacent scaffolds that connect the V-pressings on the standards with a hinge
Inventor: POUWELS KLAAS
IPC: E04G7/00
Filed: 2010-08-31
Abstract: A swivel scaffold connector (10) to join adjacent scaffolding structures is disclosed. The connector has two connecting members (16, 34) joined by a pivot (32) so that the angular relationship between the adjacent scaffolding structures may be changed while still maintaining the connection between them. The connecting members are C-shaped and include a pair of spaced apart arms (22, 24, 36, 38) to receive a V-pressing from the associated vertically extending member. The connectors are locked to the V-pressing by a wedge (25, 35) passing through each arm and the V-pressing.
Patent NZ-590010-A (NZ)
Title: Compositions and methods treating growth hormone deficiency and/or an insulin-like growth factor 1 deficiency with somatostatin and an adjuvant
Inventor: HAFFER KEITH N
IPC: A61K39/00
Filed: 2009-06-24
Abstract: Disclosed is a vaccine composition. The vaccine comprises: an immunogenic amount of somatostatin-based antigen comprising an amino acid sequence selected from the group consisting of SEQ ID NO: 3,7, and 8, as disclosed in the complete specification, and an amino acid sequence of SEQ ID NO: 1, as disclosed in the complete specification, wherein a spacer links the amino acid sequences; and an adjuvant comprising at least carboxypolyrnethylene, squalene and arabinogalactan. Also disclosed is the use of said vaccine in the treatment of a growth hormone and/or insulin-like growth factor 1 deficiency in a patient.
Patent NZ-590013-A (NZ)
Title: Amidophenoxyindazoles useful as inhibitors of c-Met
Inventor: LI TIECHAO
IPC: A61K31/4412
Filed: 2009-07-15
Abstract: Disclosed is an amidophenoxyindazole compound of structural formula depicted herein and its pharmaceutically acceptable salt, wherein: R1 is H or methyl; R2 is amino, dimethylamino, fluoro, cyclopropyl, pyridyl optionally substituted with an amino substituent or 1-2 methyl substituents, pyrazolyl optionally substituted with two methyl substituents, 2-methoxy-pyrimidin-5-yl, 4-methylsulfonylphenyl, tetrahydro-2H-pyran-4-ylamino, (tetrahydro-2H-pyran-4-yl)amino carbonyl, or a morpholin-4-yl substituent as defined in the specification. These compounds are useful as inhibitors of c-Met and are suitable for treating cancer selected from the group consisting of lung cancer, breast cancer, colorectal cancer, renal cancer, pancreatic cancer, head cancer, neck cancer, hereditary papillary renal cell carcinoma, childhood hepatocellular carcinoma, and gastric cancer.
Patent NZ-593955-A (NZ)
Title: Cutter head for dredging ground and use of a cutter head for dredging ground
Inventor: WIJMA KLAAS GEERT
IPC: E02F3/92
Filed: 2009-12-29
Abstract: 593955 Disclosed is a cutter head (10) for dredging ground under water. The cutter head is suitable for attachment rotatably around a central axis (12) to the ladder (see 2, figure 1) of a cutter suction dredger (see 1, figure 1) and for being moved through the ground (see 9, figure 1) therewith in a lateral sweeping movement. The cutter head comprises a base ring (13), a hub (14) situated at a distance in the direction of the central axis from the base ring, and a plurality of arms (15) extending from the base ring to the hub. A passage opening (16) is located between arms along which dredged ground may be discharged. The arms are provided with a first series of cutting tools (17), such as teeth, on a leading part (15a) relative to the direction of rotation of the cutter head and a second series of cutting tools on a part of the arm (15b) facing away from the central axis. The provision of the second series of cutting tools is advantageous in more efficiently dredging hard ground, such as rock.
Patent NZ-594546-A (NZ)
Title: Closure assembly for electrochemical cells
Inventor: WENDLING MATTHEW T
IPC: H01M50/572
Filed: 2010-01-27
Abstract: 594546 An electrochemical cell (10) is disclosed. The cell comprises a cylindrical container (14), having a closed bottom end, a sidewall and an open end, an electrode assembly (60) and an electrolyte disposed within the container, and an end assembly (30) positioned within the open end. The end assembly comprises a vent assembly (36), a cover (32), a positive temperature coefficient safety device [PTC] (34), and an annular gasket (40) disposed between the container and the end assembly. The gasket has an inner annular protrusion (46) that is substantially the same height, in an axial direction, as the PTC, and surrounds the PTC such that the innermost edge of the protrusion either abuts or is in close proximity to the outermost edge of the PTC. This arrangement protects the PTC from expanding due to compression during sealing and allows thermal expansion of the PTC during activation.
Patent NZ-597378-A (NZ)
Title: Treatment of multiple sclerosis with laquinimod
Inventor: TARCIC NORA
IPC: A01N43/42
Filed: 2010-06-18
Abstract: The disclosure provides for methods of reducing the relapse rate and/or reducing the accumulation of physical disability in a relapsing-remitting multiple sclerosis human patient, the method comprising orally administering to the patient a daily dose of 0.6 mg laquinimod. The disclosure also provides for pharmaceutical oral unit dosage forms of 0.6 mg laquinimod for use in reducing the relapse rate and/or for use in reducing the accumulation of physical disability in a relapsing- remitting multiple sclerosis human patient.
Patent NZ-598099-A (NZ)
Title: Closure assembly for an injection unit of plastic material with micrometrical regulation of the closure rod, and corresponding device for regulating micrometrically and fixing a threaded element
Inventor: ENRIETTI PIERO
IPC: B29C45/28
Filed: 2010-12-01
Abstract: Disclosed is a closure assembly (10), for an injection unit (11) of plastic material, comprising: a closing rod (16); a driving piston (15) adapted to drive an axial movement (f1) of the closing rod (16) between an open position (P1), in which the closing rod (16) opens an injection hole of a mould (13), and a closed position (P2), in which the closing rod (16) closes the injection hole; an adjustment element or nut (20, 21), provided of a fine-pitch threading (21a), that is adapted to be screwed or unscrewed in one sense or the other (f2) in a corresponding threaded portion (22b) of an internal seat (22), formed in the driving piston (15), in order to regulate axially, in a micrometric way, the closing rod (16) in the closed position (P2); and an elastic washer (30, 31) that is provided for cooperating with a plurality of projections and notches, formed in such internal seat (22, 22a), in order to fix the adjustment element (21) with respect to the body (15a) of the driving piston (15), once the closing rod (16) has been exactly regulated in the desired closed position (P2). Advantageously the adjustment element (21) is entirely housed in the internal seat (22) formed in the driving piston (15), whereby it does not protrude from the body (15a) of the latter.
Patent NZ-606393-A (NZ)
Title: Face protection to be fastened to a protective helmet, particularly for forestry workers
Inventor: PFANNER ANTON
IPC: A61F9/06
Filed: 2011-07-12
Abstract: A face guard (33) for fastening to a protective helmet (30), in particular for forestry workers, is disclosed. A visor (132) has two retaining arms (32) and two bearing devices (50), which can be fastened on the inside to a helmet shell (36). The retaining arms pivot the visor between an operating position, in which the visor is swung downwards and protects the face, and a parking position, in which the visor is swung upwards. Each retaining arm has a free end which can be connected to the bearing device (50) and is substantially parallel to and at a distance from the visor (132) such that a slot (37) is formed between the retaining arm (32) and visor (132). The helmet shell (36) extends through the slot. In the parking position, the visor (132) is arranged so as to fit snugly on the outer surface of the helmet shell (36).
Patent NZ-623674-A (NZ)
Title: Vip fragments and methods of use
Inventor: DUGGAN KAREN ANNETTE
IPC: A61P9/04
Filed: 2006-12-08
Abstract: Disclosed is the use of VIP(16-28) of the following sequence: , Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn, (QMAVKKYLNSILN) or conservative substitutions thereof, for the manufacture of a medicament for the treatment or prophylaxis of myocardial fibrosis and/or hypertension.
Patent NZ-627877-A (NZ)
Title: Immunotherapy against several tumors including gastrointestinal and gastric cancer
Inventor: SINGH HARPREET
IPC: G01N33/50
Filed: 2011-03-15
Abstract: Disclosed is a peptide consisting of the sequence according to SEQ ID No. 2 (SYNPLWLRI) that induces T cells crossreacting with said peptide.
Patent NZ-631800-A (NZ)
Title: A kit for forming a panel and a method of forming a panel
Inventor: LOUIE KYRIAKOULEAS
IPC: E04C2/26
Filed: 2014-09-12
Abstract: Disclosed is a kit (36) for forming a panel. The kit comprises a panel component (38) and a separate side edge portion (16). The panel component includes a surface sheet formed from a first material, and a body layer to which the surface sheet is attached. The surface sheet is generally arranged parallel to the body layer. The body layer has a thickness greater than the surface sheet, and a density less than the density of the surface sheet. The side edge is adapted to be adhered along at least one edge of the panel component. The side edge portion may also be formed of the first material. The first material may be quartz stone, marble or granite, and the panel component may be a lightweight replica of a solid panel formed of the first material. The body layer may be formed such that the majority of the volume of the body layer is void space. The kit may allow a panel component to be cut to size before applying the side portion to complete the panel.
Patent NZ-701501-A (NZ)
Title: Mask system
Inventor: FORMICA JUSTIN JOHN
IPC: A61M16/06
Filed: 2011-09-30
Abstract: A mask system for delivery of respiratory therapy to a patient includes a nares portion and a mouth portion and an inlet conduit connected to at least one of the nares portion and the mouth portion to deliver the pressurized, breathable gas. The nares portion is adapted to form a seal with the wearer’s nares. The mouth portion including a mouth chamber and a sealing portion, the sealing portion adapted to form a seal with the wearer’s mouth. The mask system is adapted to selectively utilize the nares portion and/or the mouth portion. In a first mode the system utilises both the nares portion and the mouth portion, and in a second mode utilizes the nares portion and not utilizing the mouth portion. Also disclosed is a method of converting a respiratory mask system between said first and second modes.
Patent NZ-701804-A (NZ)
Title: Delivery device and system for cartilage repair, preservation and growth by stimulation of bone-chondral interface
Inventor: VAD VIJAY
IPC: A61M37/00
Filed: 2013-04-11
Abstract: Therapeutics and methods of treatment to repair, preserve and grow cartilage are presented. In addition, systems and methods for delivering a therapeutic to a hard to reach anatomical area, such as, for example, the BCI, are presented. A cannulated delivery device provided with a cutting tip, cutting flutes and threads on its distal end can be provided. Using such an exemplary device, various novel therapies for joint and cartilage repair, preservation and generation can be implemented. Alternatively, for disc repair, a delivery device directed to percutaneous intradiscal annular repair, or “PIARES” device can be used to introduce therapeutics intradiscally. The device may have two-needles, with a first cannula/needle, with a finger grip at its distal end, and a longer inner needle to penetrate through the outer needle into the disc, and introduce therapeutics, for example, via a syringe. When provided with a septum at the inner needle’s proximal end, the PIARES device is a completely closed system, and its use minimizes trauma.
Patent NZ-702788-A (NZ)
Title: On board unit with power management
Inventor: ROGÖ JOHAN
IPC: G08G1/0967
Filed: 2013-07-03
Abstract: The present invention relates to a method for controlling an on board unit (OBU) within a communication zone of a road side unit (RSU), whereby the OBU is adapted to be set into an active mode (15), a sleep mode (14) and a tracking mode (16). The method reduces the power usage of the on board unit and comprises the steps of: setting the OBU in the active mode when the OBU is entering the communication zone (4, 7) such that a communication unit of the OBU is powered and the OBU can communicate with the RSU, and setting the OBU in the sleep mode (14) upon receiving a release command from the RSU such that all functions of the OBU except a wake-up circuit are powered down and no or a minimum of power is consumed by the OBU, wherein in the active mode, if the OBU has not reached a predetermined position within the communication zone, setting the OBU in the tracking mode upon receiving a command from the RSU, in the tracking mode, powering down the communication unit and activating a timer in the OBU, and in the tracking mode, restarting the communication unit upon expiry of a specified time limit such that the OBU transits to the active mode. The invention also relates to an on board unit for communicating with a road side unit (RSU), the OBU comprising a communication unit, a timer, a micro-computer and a counter, whereby said the communication unit is adapted to be powered down independently of the micro-computer, and the OBU is provided with a power management scheme performing the method of the invention, and in that at least the counter is available in the tracking mode.